Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Meet the women at the helm of IAVI’s Lassa program

March 6, 2025

IAVI commemorates International Women’s Day 2025.

Read more

Features

IAVI announces termination of the PEPFAR-funded ADVANCE program and staff reductions

February 27, 2025

ADVANCE produced a legacy of achievement in the search for an HIV vaccine.

Read more

Features

Fast facts about IAVI’s contributions to the 2025 Sudan virus disease outbreak in Uganda

February 26, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including the orthoebolavirus Sudan virus, since 2018.

Read more

Features

Meet the Scientist: Zandile Ciko on IAVI’s community engagement work

February 26, 2025

Zandile Ciko, a community engagement manager with IAVI in Cape Town, South Africa, discusses her work with IAVI’s community engagement team.

Read more

Features

IAVI opens new Vaccine Design and Development Laboratory space in Jersey City, NJ

February 14, 2025

Leading vaccine research and development lab now housed in an upgraded, fit-for-purpose life sciences facility.

Read more

Features

Meet the Scientist: Dr. Gaudensia Mutua on IAVI’s Lassa fever vaccine development program

December 20, 2024

Gaudensia Mutua, a medical director with IAVI in Nairobi, Kenya, discusses her work in support of IAVI’s Lassa fever vaccine program.

Read more

Features

Access to monoclonal antibodies in Africa: A call to action

December 17, 2024

IAVI and Impact Global Health issue a renewed call to action to ensure equitable access to monoclonal antibodies.

Read more

Features

Outthinking and outsmarting HIV to outdo an epidemic

December 3, 2024

Can we outsmart a virus so clever and evasive that it has challenged scientists for decades? My research seeks answers to these pressing questions.

Read more